BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15721412)

  • 21. The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer.
    King ER; Tung CS; Tsang YT; Zu Z; Lok GT; Deavers MT; Malpica A; Wolf JK; Lu KH; Birrer MJ; Mok SC; Gershenson DM; Wong KK
    Am J Surg Pathol; 2011 Jun; 35(6):904-12. PubMed ID: 21451362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of cellular apoptosis susceptibility protein in serous ovarian carcinoma: a clinicopathologic and immunohistochemical study.
    Brustmann H
    Gynecol Oncol; 2004 Jan; 92(1):268-76. PubMed ID: 14751170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular subtypes of serous borderline ovarian tumor show distinct expression patterns of benign tumor and malignant tumor-associated signatures.
    Curry EW; Stronach EA; Rama NR; Wang YY; Gabra H; El-Bahrawy MA
    Mod Pathol; 2014 Mar; 27(3):433-42. PubMed ID: 23948749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of gene expression profiles among 3 epithelial ovarian tumor subtypes using cDNA and tissue microarrays].
    Zheng M; Simon R; Kononen J; Sauter G; Mihatsch MJ; Moch H
    Ai Zheng; 2004 Jul; 23(7):771-6. PubMed ID: 15248910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma.
    Madore J; Ren F; Filali-Mouhim A; Sanchez L; Köbel M; Tonin PN; Huntsman D; Provencher DM; Mes-Masson AM
    J Pathol; 2010 Feb; 220(3):392-400. PubMed ID: 19967725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic analysis and validation of differential gene expression in ovarian serous adenocarcinomas and normal ovary.
    Bauerschlag D; Bräutigam K; Moll R; Sehouli J; Mustea A; Salehin D; Krajewska M; Reed JC; Maass N; Hampton GM; Meinhold-Heerlein I
    J Cancer Res Clin Oncol; 2013 Feb; 139(2):347-55. PubMed ID: 23090696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation.
    Choi YL; Kim J; Kwon MJ; Choi JS; Kim TJ; Bae DS; Koh SS; In YH; Park YW; Kim SH; Ahn G; Shin YK
    Histol Histopathol; 2007 Nov; 22(11):1185-95. PubMed ID: 17647191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PRK1 distribution in normal tissues and carcinomas: overexpression and activation in ovarian serous carcinoma.
    Galgano MT; Conaway M; Spencer AM; Paschal BM; Frierson HF
    Hum Pathol; 2009 Oct; 40(10):1434-40. PubMed ID: 19427017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas.
    Drapkin R; von Horsten HH; Lin Y; Mok SC; Crum CP; Welch WR; Hecht JL
    Cancer Res; 2005 Mar; 65(6):2162-9. PubMed ID: 15781627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors.
    Anglesio MS; Arnold JM; George J; Tinker AV; Tothill R; Waddell N; Simms L; Locandro B; Fereday S; Traficante N; Russell P; Sharma R; Birrer MJ; ; deFazio A; Chenevix-Trench G; Bowtell DD
    Mol Cancer Res; 2008 Nov; 6(11):1678-90. PubMed ID: 19010816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of p16INK4A expression in low-grade ovarian serous carcinomas.
    Schlosshauer PW; Deligdisch L; Penault-Llorca F; Fatemi D; Qiao R; Yao S; Pearl M; Yang Z; Sheng T; Dong J
    Int J Gynecol Pathol; 2011 Jan; 30(1):22-9. PubMed ID: 21131838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential gene expression analysis of ovarian cancer in a population isolate.
    Grazio D; Pichler I; Fuchsberger C; Zolezzi F; Guarnieri P; Heidegger H; Scherer A; Engl B; Messini S; Egarter-Vigl E; Pramstaller PP
    Eur J Gynaecol Oncol; 2008; 29(4):357-63. PubMed ID: 18714569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression and promotor methylation of p73 gene in ovarian epithelial tumors].
    Zhang YL; Guo XR; Shen DH; Cheng YX; Liang XD; Chen YX; Wang Y
    Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):33-8. PubMed ID: 22455848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical analysis of possible chemoresistance markers identified by micro-arrays on serous ovarian carcinomas.
    Têtu B; Popa I; Bairati I; L'Esperance S; Bachvarova M; Plante M; Harel F; Bachvarov D
    Mod Pathol; 2008 Aug; 21(8):1002-10. PubMed ID: 18500265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The continuum of serous tumors of low malignant potential and low-grade serous carcinomas of the ovary.
    Wong KK; Gershenson D
    Dis Markers; 2007; 23(5-6):377-87. PubMed ID: 18057521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.
    Motamed-Khorasani A; Jurisica I; Letarte M; Shaw PA; Parkes RK; Zhang X; Evangelou A; Rosen B; Murphy KJ; Brown TJ
    Oncogene; 2007 Jan; 26(2):198-214. PubMed ID: 16832351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization.
    Hauptmann S; Denkert C; Koch I; Petersen S; Schlüns K; Reles A; Dietel M; Petersen I
    Hum Pathol; 2002 Jun; 33(6):632-41. PubMed ID: 12152163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of gene amplification and prognostic markers in ovarian cancer using comparative genomic hybridization for microarrays and immunohistochemical analysis for tissue microarrays.
    Mayr D; Kanitz V; Anderegg B; Luthardt B; Engel J; Löhrs U; Amann G; Diebold J
    Am J Clin Pathol; 2006 Jul; 126(1):101-9. PubMed ID: 16753589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification by cDNA microarray of genes involved in ovarian carcinogenesis.
    Ono K; Tanaka T; Tsunoda T; Kitahara O; Kihara C; Okamoto A; Ochiai K; Takagi T; Nakamura Y
    Cancer Res; 2000 Sep; 60(18):5007-11. PubMed ID: 11016619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.